Loading insider details...
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 5,781 EWTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,781 | n/a |
| May 5, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Sale | 5,230 | $163.7K |
| Apr 2, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 28,662 | $202.9K |
| Mar 31, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 21,338 | $151.1K |
| Mar 30, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Sale | 9,623 | $298.1K |
| Aug 14, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,781 | n/a |
| May 7, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 10,417 | n/a |
| Jan 30, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 25,000 | $177.0K |
| Sep 24, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Sale | 7,162 | $202.6K |
| Aug 14, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 138,750 | n/a |